Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,468 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Tolerability and Preliminary Outcomes of Adjuvant T-DM1 in HER2-Positive Breast Cancer After Neoadjuvant Therapy: The ATD Study.
Krasniqi E, Filomeno L, Arcuri T, Di Lisa FS, Astone A, Cutigni C, Foglietta J, Nunzi M, Rossi R, Minelli M, Meattini I, Visani L, Scialino J, Livi L, Moscetti L, Marchetti P, Botticelli A, Paris I, Pavese F, D'Angelo T, Sini V, Stani S, Valerio MR, Grassadonia A, Tinari N, Mazzotta M, Vergati M, D'Auria G, Gamucci T, D'Onofrio L, Gasparro S, Roselli A, Fulvi A, Ferretti G, Torchia A, Giordano M, Greco F, Pantano F, Tonini G, Fabbri A, Bria E, Garufi G, Fiorio E, Raffaele M, Pistelli M, Berardi R, Saltarelli R, Kayal R, Ferranti FR, Cannita K, Irelli A, D'Ostilio N, De Rossi C, Palumbo R, Cariello A, Sanguineti G, Calabrò F, Pizzuti L, Barba M, Botti C, Pelle F, Cappelli S, Cavicchi F, Puccica I, Villanucci A, Sperduti I, Ciliberto G, Vici P. Krasniqi E, et al. Among authors: marchetti p. Cancers (Basel). 2024 Dec 7;16(23):4104. doi: 10.3390/cancers16234104. Cancers (Basel). 2024. PMID: 39682290 Free PMC article.
Exploring Genomic Biomarkers for Pembrolizumab Response: A Real-World Approach and Patient Similarity Network Analysis Reveal DNA Response and Repair Gene Mutations as a Signature.
Filetti M, Occhipinti M, Cirillo A, Scirocchi F, Ugolini A, Giusti R, Lombardi P, Daniele G, Botticelli A, Lo Russo G, De Braud F, Marchetti P, Nuti M, Ferretti E, Farina L, Rughetti A, Petti M. Filetti M, et al. Among authors: marchetti p. Cancers (Basel). 2024 Nov 26;16(23):3955. doi: 10.3390/cancers16233955. Cancers (Basel). 2024. PMID: 39682144 Free PMC article.
Community case study for surveillance and early case-detection of SARS-CoV-2 infections across high-risk key populations: the Sentinella programme.
Tebon M, Davis RJ, Savoldi A, Soriolo N, Walters SEJ, Nosè M, Barbui C, Turrini G, Danese E, Lippi G, Cecchetto R, Mazzariol A, Gibellini D, Caliskan G, Marchetti P, Verlato G, Princivalle A, Porru S, Tacconelli E, De Nardo P. Tebon M, et al. Among authors: marchetti p. Front Public Health. 2024 Oct 23;12:1432157. doi: 10.3389/fpubh.2024.1432157. eCollection 2024. Front Public Health. 2024. PMID: 39512710 Free PMC article.
Trastuzumab Duocarmazine in Pretreated Human Epidermal Growth Factor Receptor 2-Positive Advanced or Metastatic Breast Cancer: An Open-Label, Randomized, Phase III Trial (TULIP).
Turner N, Saura C, Aftimos P, van den Tweel E, Oesterholt M, Koper N, Colleoni M, Kaczmarek E, Punie K, Song X, Armstrong A, Bianchi G, Stradella A, Ladoire S, Lim JSJ, Quenel-Tueux N, Tan TJ, Escrivá-de-Romaní S, O'Shaughnessy J; TULIP Trial Investigators. Turner N, et al. J Clin Oncol. 2024 Oct 23:JCO2400529. doi: 10.1200/JCO.24.00529. Online ahead of print. J Clin Oncol. 2024. PMID: 39442070
Predicting the Risk of Adverse Neonatal Outcomes in Women With Insulin-Treated Diabetes: Is It Time for a Pregnancy-Specific Glycemic Risk Index (GRI)?
Citro F, Bianchi C, Belcari T, Galleano F, Venturi C, Battini L, Marchetti P, Bertolotto A, Aragona M. Citro F, et al. Among authors: marchetti p. J Diabetes Sci Technol. 2024 Oct 17:19322968241289957. doi: 10.1177/19322968241289957. Online ahead of print. J Diabetes Sci Technol. 2024. PMID: 39417492 Free PMC article.
Survival of Patients with Metastatic Melanoma Treated with Ipilimumab after PD-1 Inhibitors: A Single-Center Real-World Study.
Verkhovskaia S, Falcone R, Di Pietro FR, Carbone ML, Samela T, Perez M, Poti G, Morelli MF, Zappalà AR, Di Rocco ZC, Morese R, Piesco G, Chesi P, Marchetti P, Abeni D, Failla CM, De Galitiis F. Verkhovskaia S, et al. Among authors: marchetti p. Cancers (Basel). 2024 Oct 4;16(19):3397. doi: 10.3390/cancers16193397. Cancers (Basel). 2024. PMID: 39410017 Free PMC article.
1,468 results